通过通过OTUB1-介导的全方位化来探索Aiolos在肺癌中的致癌潜力
Xiuwen Zhang1, Mei Zhong1, Xinyue Fu2
1Tianjin Key Laboratory of Lung Cancer Metastasis and Tumor Microenvironment, Tianjin Lung Cancer Institute, Tianjin Medical University General Hospital, Tianjin, 300052, China.
Heliyon
|September 24, 2024
概括
艾洛斯 (IKZF3) 促进肺癌细胞的生长和扩散. 它与OTUB1的相互作用可能会推动疾病的进展,为肺癌提供潜在的新治疗点.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 细胞生物学 细胞生物学
背景情况:
- 艾洛斯 (IKZF3) 是固体瘤中发现的转录因子,但其在肺癌中的作用尚不清楚.
- 目前对Aiolos的研究主要侧重于其在造血系统中的功能.
研究的目的:
- 为了调查Aiolos在肺癌细胞增殖,迁移和入侵中的作用.
- 为了确定艾奥洛斯在肺癌中的潜在相互作用蛋白质.
- 探索Aiolos及其相互作用伙伴在肺癌进展中的功能关系.
主要方法:
- 评估了Aiolos过度表达对肺癌细胞行为的影响.
- 进行共免疫沉测试以确定Aiolos相互作用的蛋白质.
- 研究了OTUB1对Aiolos无处不在和功能的影响.
主要成果:
- 艾洛斯的过度表达被发现可以增强肺癌细胞的增殖,迁移和入侵.
- OTUB1被确定为一种与Aiolos结合的蛋白质.
- OTUB1降低了Aiolos的无处不在,可能会影响其在细胞迁移和入侵中的生物功能.
结论:
- 艾洛斯在促进肺癌进展方面发挥着重要作用.
- 艾奥洛斯和OTUB1之间的相互作用会影响肺癌细胞的功能.
- 艾洛斯和OTUB1是肺癌治疗的潜在治疗点.
相关概念视频
Cancer-Critical Genes I: Proto-oncogenes
8.7K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.7K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
lncRNA - Long Non-coding RNAs
8.5K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.5K


